StaceyGoodmanMD

Hematology • Nashville, TN

Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Goodman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Goodman's full profile

Already have an account?

Office
3601 Tvc
Nashville, TN 37232
Phone+1 615-936-8422
Is this information wrong?

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993
Vanderbilt University Medical CenterResidency, Internal Medicine, 1987 - 1990
New York University School of MedicineClass of 1987

Certifications & Licensure

TN State Medical License 1993 - 2023
AL State Medical License 2020 - 2020
American Board of Internal Medicine Hematology

Clinical Trials

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
Completed
Phase 3
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
Terminated
Phase 2, Phase 3
Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
Completed
Phase 3
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) Start of enrollment: 2009 Apr 01
Completed
Phase 2
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Start of enrollment: 2016 Mar 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

10 citations
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardle...
, , , , , , , , , , , , , , , , , , , , , , , > ;Transplantation and Cellular Therapy. 2021 Mar 1
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Tran...
Dilan A Patel, Karina A. Mendoza, Heidi Chen, Brian G. Engelhardt, Bipin N. Savani, Stacey Goodman, Jeremy L. Warner, Adetola A. Kassim, Michael Byrne, Wichai Chinrata...> ;Journal of Hematology. 2021 Feb 6
New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.
Brendan L. Mangan, Dilan A Patel, Heidi Chen, Katie S. Gatwood, Michael Byrne, Salyka Sengsayadeth, Stacey Goodman, Bhagirathbhai Dholaria, Adetola A. Kassim, Madan Ja...> ;Ejhaem. 2020 Sep 23
22 citations
Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.
Eun-jeong Kim, Benjamin Holmes, Shi Huang, Ricardo M. Lugo, Asad A. Aboud, Stacey Goodman, Rebecca Hung, David Slosky, William G. Stevenson, Gregory F. Michaud, Roy M....> ;Europace. 2020 Aug 1
39 citations
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.
Michael Byrne, Nathalie Danielson, Salyka Sengsayadeth, Adrianne Rasche, Katie Culos, Katie S. Gatwood, Houston Wyatt, Wichai Chinratanalab, Bhagirathbhai Dholaria, P....> ;American Journal of Hematology. 2020 Jun 15
26 citations
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the B...
Sergio Giralt, Luciano J. Costa, David G. Maloney, Amrita Krishnan, Mingwei Fei, Joseph H. Antin, Claudio G. Brunstein, Nancy L. Geller, Stacey Goodman, Parameswaran H...> ;Biology of Blood and Marrow Transplantation. 2020 Apr 1
7 citations
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma.
Dilan A Patel, Ragisha Gopalakrishnan, Brian G. Engelhardt, Evonne McArthur, Salyka Sengsayadeth, Katie Culos, Michael Byrne, Stacey Goodman, Bipin N. Savani, Wichai C...> ;Bone Marrow Transplantation. 2020 Jan 28
4 citations
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An In...
Vipul Sheth, Vanessa E Kennedy, Hugues de Lavallade, Donal P. McLornan, Victoria T Potter, Brian G. Engelhardt, Bipin N. Savani, Wichai Chinratanalab, Stacey Goodman, ...> ;Frontiers in Oncology. 2019 Jul 10
102 citations
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.
, , , , , , , , , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2019 Jun 12
2 citations
Subcutaneous scalp nodule as the presenting symptom of systemic light-chain amyloidosis.
Joseph Tadros, Stacey Goodman, Eric R. Tkaczyk> ;Dermatology Practical & Conceptual. 2018 Jul 31
3 citations
Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy.
C. Amos Clark, Claudio A. Mosse, Heidi Chen, Michael Byrne, Wichai Chinratanalab, Brian G. Engelhardt, Stacey Goodman, Shelton L. Harrell, Adetola A. Kassim, Bipin N. ...> ;Bone Marrow Transplantation. 2018 Jun 18
15 citations
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Jennifer Huang, Sharon Phillips, Michael Byrne, Wichai Chinratanalab, Brian G. Engelhardt, Stacey Goodman, Shelton L. Harrell, Madan Jagasia, Adetola A. Kassim, Kyle T...> ;Bone Marrow Transplantation. 2018 Apr 27
2 citations
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia
Katie S. Gatwood, Kathryn A. Culos, Laura A Binari, Brian G. Engelhardt, Adetola A. Kassim, Michael Byrne, Stacey Goodman, Wichai Chinratanalab, Salyka Sengsayadeth, J...> ;Bone Marrow Transplantation. 2018 Mar 14
43 citations
Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count
Vanessa E Kennedy, Heidi Chen, Bipin N. Savani, John P. Greer, Adetola A. Kassim, Brian G. Engelhardt, Stacey Goodman, Salyka Sengsayadeth, Wichai Chinratanalab, Madan...> ;Biology of Blood and Marrow Transplantation. 2018 Jan 1
5 citations
Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.
Oluchi Oke, Tarsheen K. Sethi, Stacey Goodman, Sharon Phillips, Ilka Decker, Samuel M. Rubinstein, Beatrice P. Concepcion, Sarah N. Horst, Madan Jagasia, Adetola A. Ka...> ;Biology of Blood and Marrow Transplantation. 2017 Sep 1
11 citations
Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis.
Samuel M. Rubinstein, Liping Du, Beatrice P. Concepcion, Stacey Goodman, Shelton L. Harrell, Sara N. Horst, Daniel J. Lenihan, David Slosky, Agnes B. Fogo, Anthony Lan...> ;Amyloid. 2017 Jul 31
21 citations
Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration
Alexandra J. Ritts, Kristopher J. Swiger, Jai Singh, Stacey Goodman, Daniel J. Lenihan> ;Heart Failure Clinics. 2017 Apr 1
11 citations
The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
Ilka Decker, Stacey Goodman, Sharon Phillips, Daniel J. Lenihan> ;British Journal of Haematology. 2017 May 1
14 citations
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling
Romany A. N. Johnpulle, Sophie Paczesny, Dae Kwang Jung, Etienne Daguindau, Madan Jagasia, Bipin N. Savani, Wichai Chinratanalab, Stacey Goodman, John P. Greer, Adetol...> ;Biology of Blood and Marrow Transplantation. 2017 Mar 1
9 citations
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allo...
Vanessa E Kennedy, Bipin N. Savani, John P. Greer, Adetola A. Kassim, Brian G. Engelhardt, Stacey Goodman, Salyka Sengsayadeth, Wichai Chinratanalab, Madan Jagasia> ;Biology of Blood and Marrow Transplantation. 2016 Oct 1
Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation.
Brian G. Engelhardt, Sophie Paczesny, Dae Kwang Jung, Etienne Daguindau, Madan Jagasia, Bipin N. Savani, Wichai Chinratanalab, Stacey Goodman, John P. Greer, Adetola A...> ;Haematologica. 2016 May 1
4 citations
Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials.
Salyka Sengsayadeth, Bipin N. Savani, Madan Jagasia, Stacey Goodman, John P. Greer, Heidi Chen, Wichai Chinratanalab, Adetola A. Kassim, Brian G. Engelhardt> ;Bone Marrow Transplantation. 2014 Feb 1
2 citations
New allergies after cord blood transplantation.
Leigh Ann Vaughan, Mary Vu, Salyka Sengsayadeth, C. Lucid, Carey Clifton, Karen Mccarty, David Hagaman, Jennifer Domm, Adetola A. Kassim, Wichai Chinratanalab, Stacey ...> ;Cytotherapy. 2013 Oct 1
58 citations
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers
Salyka Sengsayadeth, Madan Jagasia, Brian G. Engelhardt, Adetola A. Kassim, Stephen A. Strickland, Stacey Goodman, C. Lucid, Cindy L. Vnencak-Jones, John P. Greer, Bip...> ;Bone Marrow Transplantation. 2012 Dec 1
20 citations
Superior Long-Term Outcome of Patients With Early Transformation of Non-Hodgkin Lymphoma Undergoing Stem Cell Transplantation
Nishitha Reddy, Olalekan O. Oluwole, John P. Greer, Stacey Goodman, Brian G. Engelhardt, Madan Jagasia, Bipin N. Savani> ;Clinical Lymphoma, Myeloma & Leukemia. 2012 Dec 1
Join now to see all